Benitec Biopharma logo
Benitec Biopharma
BNTC | NASDAQ
Chart Builder DCF Calculator
$8.54
-$0.50 (-5.53%)
At close: Nov 16, 2026, 4:00 PM ET
$8.54
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

Benitec Biopharma Company Profile

Company profile explained

Company Profile

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Key Executives

Name Position
Jerel A. Banks Executive Chairman & Chief Executive Officer
Sophie Mukadam Chief Operating Officer
Claudia Kloth Senior Vice President of Manufacturing
Megan Joan Boston CFO & Secretary
Michael Graham Head of Discovery & Founding Scientist

Latest SEC Filings

Date Type Title
Oct 28, 2026 8-K Current Report
Oct 20, 2026 DEFA14A Filing
Oct 20, 2026 DEF 14A Filing
Oct 05, 2026 8-K Current Report
Sep 30, 2026 8-K Current Report
Sep 24, 2026 8-K Current Report
Sep 21, 2026 EFFECT Filing
Sep 14, 2026 S-3 Filing
Sep 14, 2026 10-K Annual Report
Sep 14, 2026 8-K Current Report
View All SEC Filings ➞
Benitec Biopharma
Benitec Biopharma logo
Country United States
IPO Date Jun 24, 2014
Industry Biotechnology
Sector Healthcare
Employees 24
CEO Jerel A. Banks

Contact Details

3940 Trust Way Hayward, California 94545 United States

Stock Details

Ticker Symbol BNTC
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001808898
CUSIP Number 08205P209
ISIN Number US08205P2092
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.